EB SECURITIES (06178): Qin Xiaozheng resigns as non-executive director.

16:49 24/06/2026

Guangda Securities (06178) announced that the board of directors received a resignation report from Mr. Qin Xiaozheng, a non-executive director of the company, on June 24, 2026. Due to work reasons, Mr. Qin Xiaozheng resigned from his position as non-executive director of the company and member of the board's Strategic and Sustainable Development Committee, and will no longer hold any position in the company or its subsidiaries. There are no outstanding unfulfilled public commitments.

EB SECURITIES (06178) announced that the board of directors received the resignation report from Mr. Qin Xiaozheng, a non-executive director of the company, on June 24, 2026. Due to work reasons, Mr. Qin Xiaozheng resigned from his position as a non-executive director of the company and as a member of the board's Strategic and Sustainable Development Committee. He will no longer hold any position in the company or its subsidiaries, and there are no unfulfilled public commitments.

Meiwei Bio (688062.SH): The clinical trial application for 9MW5211 injection has been approved by the National Medical Products Administration.

MABPHARM-B(02181): The application for the marketing registration of CMAB807X class Sushu (Dusulimab Injection) has been approved.

PRU (02378) spent 400,000.09 pounds on June 23 to repurchase 39,650 shares.

Meiwei Bio (688062.SH): The clinical trial application for 9MW5211 injection has been approved by the National Medical Products Administration.

MABPHARM-B(02181): The application for the marketing registration of CMAB807X class Sushu (Dusulimab Injection) has been approved.

PRU (02378) spent 400,000.09 pounds on June 23 to repurchase 39,650 shares.